News Overview

A team from Hannover Medical School, which also includes RESIST researchers, publishes the first European study of this kind in the Lancet journal "EBioMedicine” / The course of infection with the co [...]

“I am very pleased to join this community of excellent scientists and physicians and help RESIST now to achieve its goals”, says Michele Proietti, who is professor for Genetics of Immundysregulation [...]

RESIST took part at the virtual career fair "Research in Germany" on July 7th, where numerous international students and postdoctoral researchers interested in doing research in Germany have been loo [...]

SARS-CoV-2 has made it very clear to us: As we age, the defense by our immune system against viruses can be very poor sometimes. Unfortunately, also vaccinations show often only weak effects in elder [...]

“I am very pleased that I can support RESIST now to achieve its goals”, says Chris Lauber, who is since mid-June professor for Computational Virology at MHH. Professor Lauber works at the Institute f [...]

Numerous RESIST scientists in the various institutions have expanded their work and are now also focusing on SARS-CoV-2: Professor Dr. Luka Čičin-Šain at the HZI is developing new technologies for im [...]

People who have successfully mastered an infection with SARS-CoV-2 have various protective antibodies in their blood. Some of these substances are particularly effective. Detecting these highly poten [...]

In his search for a suitable vaccine against the coronavirus SARS-CoV-2, Professor Förster relies on old friends. In cooperation with the Ludwig-Maximilians-Universität München (LMU), the co-speaker [...]

Sarina Ravens and Jens Bosse received their certificates of professorship appointment on 30th April 2020 at the MHH Presidium. Since May, they have obtained the first professorships financed by the C [...]

RESIST-Scientist Professor Pietschmann leads the German part of an international consortium of scientists. This research network is searching for substances that act against SARS-CoV-2 in the world's [...]

Many different research projects on SARS-CoV-2 are carried out in the Cluster of Excellence RESIST - always with the aim of protecting and treating people in the best possible way. Professor Schulz g [...]

Professor Schulz answered numerous questions about the novel coronavirus, together with MHH colleagues. The interview can be found here (on the homepage of the Hanover Medical School). More informat [...]

Dr. Gisa Gerold, Researcher of the TWINCORE – Centre for Experimental and Clinical Infection Research and visiting professor at Umea University in Sweden, is associated with RESIST: Her PhD student L [...]

Five researchers of our Cluster of Excellence RESIST have been elected to the Review Boards of the German Research Foundation (DFG): Professor Dr. Gesine Hansen has been elected to the Review Board " [...]

The RESIST team of Professor Dr. Doris Steinemann and Professor Dr. Thomas Illig (right) is proud of a new large-scale device: the BioNano Saphyr. This technology can be used to investigate genetic c [...]

RESIST research is the current cover story of MHHinfo. It provides an overview, illustrates research on specific diseases using patient examples, explains the cohorts for conducting clinical studies [...]

RESIST scientist Professor Dr. Michael Meyer-Hermann has used computer simulations to investigate how the natural formation of rare antibodies with a special ability is promoted: These so-called broa [...]

How many people in Germany have a congenital immunodeficiency that makes them particularly susceptible to infectious diseases? And which of the approximately 200 known forms of immunodeficiencies do [...]

The immune system protects against the formation of biofilms. That was previously believed. In contrast, however, now RESIST researchers led by Professor Dr. Reinhold Förster have discovered that the [...]

"I am very pleased that our Cluster of Excellence RESIST has now its own homepage and I cordially invite you to take a look at it," says RESIST speaker Professor Dr. Thomas Schulz. Click on "About us [...]

Some people become only mildly ill when they ’catch’ viral or bacterial infections, whereas others are affected much more severely. But what are the reasons for these differences? And how can the cour [...]